Curamir Therapeutics

Recent Finacing

Series A

Recent Raise

$10M

Curamir Therapeutics is a Woburn, MA biotechnology company developing miRNA-engineered cancer therapeutics using a proprietary miRNA engineering platform and academic-licensed technologies to address oncology drug resistance and toxicity.

Founded 2019

Massachusetts, United States

1-10

Private

curamirtherapeutics.com

Highlights

Focus Areas

Biotechnology

Therapeutics

Recent Investors

Financials

$10M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Curamir Therapeutics.